Skip to main content
Top
Published in: Neuroradiology 9/2013

01-09-2013 | Interventional Neuroradiology

Relationship between diabetes mellitus with dural arteriovenous fistula

Authors: Dong-Geun Lee, Lin Bo Zhao, Jae Ho Shim, Deok Hee Lee, Dae Chul Suh

Published in: Neuroradiology | Issue 9/2013

Login to get access

Abstract

Introduction

The aetiology of dural arteriovenous fistula (DAVF) is not well known, but it has been suggested that abnormality in angiogenesis plays a pathological role. Abnormality in angiogenesis is also involved in diabetes mellitus (DM). The purpose of this study was to quantify the relation between DAVF and DM in a Korean population.

Methods

Medical records of 192 patients with DAVF between 2002 and 2011 were reviewed. Age, sex and the presence of DM, hypertension, hyperlipidaemia, stroke, coronary artery disease and cancers were compared between DAVF and control subjects. Data for control were obtained from the Korean National Health and Nutrition Examination Survey. The relationship of DM and DAVF location, presenting symptoms (benign vs. aggressive) and classification (Borden and Geibprasert) were assessed using the Pearson’s chi-square test.

Results

Prevalence of DM was higher in DAVF patients (19.8 %) than in controls (9.5 %; p = 0.004). Univariate analysis showed that DM (odds ratio (OR), 2.356; 95 % confidence interval (CI), 1.634–3.399; p < 0.001) and age (OR, 1.022; 95 % CI, 1.012–1.032; p < 0.001) increased the odds of DAVF. This was supported by multivariate analysis (DM: OR, 2.092; 95 % CI, 1.391–3.145; p = 0.0004 and Age: OR, 1.021; 95 % CI, 1.009–1.033; p = 0.001). When these analyses were repeated after stratification by sex, there was no relation between age and DAVF in men. Borden II and III (p = 0.038) and aggressive symptoms (p = 0.023) were related to DM.

Conclusion

There was a positive relation between DM and DAVF in a Korean population. DAVFs with aggressive symptoms and behaviour were more commonly related to DM.
Literature
1.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed
2.
go back to reference Golden SH (2011) Emerging therapeutic approaches for the management of diabetes mellitus and macrovascular complications. Am J Cardiol 108:59B–67BCrossRefPubMed Golden SH (2011) Emerging therapeutic approaches for the management of diabetes mellitus and macrovascular complications. Am J Cardiol 108:59B–67BCrossRefPubMed
3.
go back to reference Edwards MS, Wilson DB, Craven TE et al (2005) Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis 46:214–224CrossRefPubMed Edwards MS, Wilson DB, Craven TE et al (2005) Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis 46:214–224CrossRefPubMed
4.
go back to reference Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR (2007) Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke 38:1739–1743CrossRefPubMed Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR (2007) Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke 38:1739–1743CrossRefPubMed
5.
go back to reference Martin A, Komada MR, Sane DC (2003) Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23:117–145CrossRefPubMed Martin A, Komada MR, Sane DC (2003) Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23:117–145CrossRefPubMed
7.
go back to reference Lasjaunias P, Chiu M, ter Brugge K, Tolia A, Hurth M, Bernstein M (1986) Neurological manifestations of intracranial dural arteriovenous malformations. J Neurosurg 64:724–730CrossRefPubMed Lasjaunias P, Chiu M, ter Brugge K, Tolia A, Hurth M, Bernstein M (1986) Neurological manifestations of intracranial dural arteriovenous malformations. J Neurosurg 64:724–730CrossRefPubMed
8.
go back to reference Davies MA, Saleh J, ter Brugge K, Willinsky R, Wallace MC (1997) The natural history and management of intracranial dural arteriovenous fistulae. Part 1: benign lesions. Interv Neuroradiol 3:295–302PubMed Davies MA, Saleh J, ter Brugge K, Willinsky R, Wallace MC (1997) The natural history and management of intracranial dural arteriovenous fistulae. Part 1: benign lesions. Interv Neuroradiol 3:295–302PubMed
9.
go back to reference Davies MA, ter Brugge K, Willinsky R, Coyne T, Saleh J, Wallace MC (1996) The validity of classification for the clinical presentation of intracranial dural arteriovenous fistulas. J Neurosurg 85:830–837CrossRefPubMed Davies MA, ter Brugge K, Willinsky R, Coyne T, Saleh J, Wallace MC (1996) The validity of classification for the clinical presentation of intracranial dural arteriovenous fistulas. J Neurosurg 85:830–837CrossRefPubMed
10.
go back to reference Geibprasert S, Krings T, Pereira V, Pongpech S, Piske R, Lasjaunias P (2009) Clinical characteristics of dural arteriovenous shunts in 446 patients of three different ethnicities. Interv Neuroradiol 15:395–400PubMed Geibprasert S, Krings T, Pereira V, Pongpech S, Piske R, Lasjaunias P (2009) Clinical characteristics of dural arteriovenous shunts in 446 patients of three different ethnicities. Interv Neuroradiol 15:395–400PubMed
11.
go back to reference Satomi J, van Dijk JM, ter Brugge K, Willinsky RA, Wallace MC (2002) Benign cranial dural arteriovenous fistulas: outcome of conservative management based on the natural history of the lesion. J Neurosurg 97:767–770 Satomi J, van Dijk JM, ter Brugge K, Willinsky RA, Wallace MC (2002) Benign cranial dural arteriovenous fistulas: outcome of conservative management based on the natural history of the lesion. J Neurosurg 97:767–770
12.
go back to reference Choi BS, Park JW, Kim JL et al (2011) Treatment strategy based on multimodal management outcome of cavernous sinus dural arteriovenous fistula (CSDAVF). Neurointervention 6:6–12CrossRefPubMed Choi BS, Park JW, Kim JL et al (2011) Treatment strategy based on multimodal management outcome of cavernous sinus dural arteriovenous fistula (CSDAVF). Neurointervention 6:6–12CrossRefPubMed
13.
go back to reference Houser OW, Campbell JK, Campbell RJ, Sundt TM Jr (1979) Arteriovenous malformation affecting the transverse dural venous sinus—an acquired lesion. Mayo Clin Proc 54:651–661PubMed Houser OW, Campbell JK, Campbell RJ, Sundt TM Jr (1979) Arteriovenous malformation affecting the transverse dural venous sinus—an acquired lesion. Mayo Clin Proc 54:651–661PubMed
14.
go back to reference Chaudhary MY, Sachdev VP, Cho SH, Weitzner I Jr, Puljic S, Huang YP (1982) Dural arteriovenous malformation of the major venous sinuses: an acquired lesion. AJNR Am J Neuroradiol 3:13–19PubMed Chaudhary MY, Sachdev VP, Cho SH, Weitzner I Jr, Puljic S, Huang YP (1982) Dural arteriovenous malformation of the major venous sinuses: an acquired lesion. AJNR Am J Neuroradiol 3:13–19PubMed
15.
go back to reference Uranishi R, Nakase H, Sakaki T (1999) Expression of angiogenic growth factors in dural arteriovenous fistula. J Neurosurg 91:781–786CrossRefPubMed Uranishi R, Nakase H, Sakaki T (1999) Expression of angiogenic growth factors in dural arteriovenous fistula. J Neurosurg 91:781–786CrossRefPubMed
16.
go back to reference Kurata A, Miyasaka Y, Oka H et al (1999) Spontaneous carotid cavernous fistulas with special reference to the influence of estradiol decrease. Neurol Res 21:631–639PubMed Kurata A, Miyasaka Y, Oka H et al (1999) Spontaneous carotid cavernous fistulas with special reference to the influence of estradiol decrease. Neurol Res 21:631–639PubMed
17.
go back to reference Geibprasert S, Pereira V, Krings T et al (2008) Dural arteriovenous shunts: a new classification of craniospinal epidural venous anatomical bases and clinical correlations. Stroke 39:2783–2794CrossRefPubMed Geibprasert S, Pereira V, Krings T et al (2008) Dural arteriovenous shunts: a new classification of craniospinal epidural venous anatomical bases and clinical correlations. Stroke 39:2783–2794CrossRefPubMed
18.
go back to reference Terada T, Tsuura M, Komai N et al (1996) The role of angiogenic factor bFGF in the development of dural AVFs. Acta Neurochir (Wien) 138:877–883CrossRef Terada T, Tsuura M, Komai N et al (1996) The role of angiogenic factor bFGF in the development of dural AVFs. Acta Neurochir (Wien) 138:877–883CrossRef
19.
go back to reference Tirakotai W, Bertalanffy H, Liu-Guan B, Farhoud A, Sure U (2005) Immunohistochemical study in dural arteriovenous fistulas and possible role of local hypoxia for the de novo formation of dural arteriovenous fistulas. Clin Neurol Neurosurg 107:455–460CrossRefPubMed Tirakotai W, Bertalanffy H, Liu-Guan B, Farhoud A, Sure U (2005) Immunohistochemical study in dural arteriovenous fistulas and possible role of local hypoxia for the de novo formation of dural arteriovenous fistulas. Clin Neurol Neurosurg 107:455–460CrossRefPubMed
20.
go back to reference Borden JA, Wu JK, Shucart WA (1995) A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg 82:166–179CrossRefPubMed Borden JA, Wu JK, Shucart WA (1995) A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg 82:166–179CrossRefPubMed
21.
go back to reference Lasjaunias P, Berenstein A, ter Brugge K (2006) Surgical neuroangiography 3: clinical and interventional aspects in children. Springer, Berlin Lasjaunias P, Berenstein A, ter Brugge K (2006) Surgical neuroangiography 3: clinical and interventional aspects in children. Springer, Berlin
23.
go back to reference Van Dijk JM, ter Brugge K, Willinsky RA, Farb RI, Wallace MC (2002) Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients. Stroke 33:1578–1583 Van Dijk JM, ter Brugge K, Willinsky RA, Farb RI, Wallace MC (2002) Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients. Stroke 33:1578–1583
24.
go back to reference Awad IA, Little JR, Akarawi WP, Ahl J (1990) Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg 72:839–850CrossRefPubMed Awad IA, Little JR, Akarawi WP, Ahl J (1990) Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg 72:839–850CrossRefPubMed
25.
go back to reference Willinsky R, ter Brugge K, Lasjaunias P, Montanera W (1990) The variable presentations of craniocervical and cervical dural arteriovenous malformations. Surg Neurol 34:118–123CrossRefPubMed Willinsky R, ter Brugge K, Lasjaunias P, Montanera W (1990) The variable presentations of craniocervical and cervical dural arteriovenous malformations. Surg Neurol 34:118–123CrossRefPubMed
26.
go back to reference Korean Ministry of Health and Welfare. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1). Korea: Korean Ministry of Health and Welfare, 2011 Korean Ministry of Health and Welfare. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1). Korea: Korean Ministry of Health and Welfare, 2011
27.
go back to reference Bae YS, Park KY, Lee JW, Kim DJ, Kim DI, Huh SK (2008) Therapeutic results of intracrainal dural arteriovenous fistula. Korean J Cerebrovasc Surg 10:496–501 Bae YS, Park KY, Lee JW, Kim DJ, Kim DI, Huh SK (2008) Therapeutic results of intracrainal dural arteriovenous fistula. Korean J Cerebrovasc Surg 10:496–501
28.
go back to reference Blann AD, Belgore FM, McCollum CN, Silverman S, Lip PL, Lip GY (2002) Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. Clin Sci (Lond) 102:187–194CrossRef Blann AD, Belgore FM, McCollum CN, Silverman S, Lip PL, Lip GY (2002) Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. Clin Sci (Lond) 102:187–194CrossRef
29.
go back to reference Xia P, Aiello LP, Ishii H et al (1996) Characterization of vascular endothelial growth factor’s effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018–2026CrossRefPubMed Xia P, Aiello LP, Ishii H et al (1996) Characterization of vascular endothelial growth factor’s effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018–2026CrossRefPubMed
30.
go back to reference Simon M, Grone HJ, Johren O et al (1995) Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240–F250PubMed Simon M, Grone HJ, Johren O et al (1995) Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240–F250PubMed
31.
go back to reference Cooper ME, Vranes D, Youssef S et al (1999) Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48:2229–2239CrossRefPubMed Cooper ME, Vranes D, Youssef S et al (1999) Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48:2229–2239CrossRefPubMed
32.
go back to reference Zimering MB, Eng J (1996) Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria or proteinuria. J Clin Endocrinol Metab 81:4446–4452CrossRefPubMed Zimering MB, Eng J (1996) Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria or proteinuria. J Clin Endocrinol Metab 81:4446–4452CrossRefPubMed
33.
go back to reference Preissner KT, Kanse SM, Hammes HP (1997) Integrin chatter and vascular function in diabetic retinopathy. Horm Metab Res 29:643–645CrossRefPubMed Preissner KT, Kanse SM, Hammes HP (1997) Integrin chatter and vascular function in diabetic retinopathy. Horm Metab Res 29:643–645CrossRefPubMed
34.
go back to reference Suh DC, Lee JH, Kim SJ et al (2005) New concept in cavernous sinus dural arteriovenous fistula: correlation with presenting symptom and venous drainage patterns. Stroke 36:1134–1139CrossRefPubMed Suh DC, Lee JH, Kim SJ et al (2005) New concept in cavernous sinus dural arteriovenous fistula: correlation with presenting symptom and venous drainage patterns. Stroke 36:1134–1139CrossRefPubMed
35.
go back to reference Hamada Y, Goto K, Inoue T et al (1997) Histopathological aspects of dural arteriovenous fistulas in the transverse-sigmoid sinus region in nine patients. Neurosurgery 40:452–456, discussion 456–458PubMed Hamada Y, Goto K, Inoue T et al (1997) Histopathological aspects of dural arteriovenous fistulas in the transverse-sigmoid sinus region in nine patients. Neurosurgery 40:452–456, discussion 456–458PubMed
36.
go back to reference Cognard C, Gobin YP, Pierot L et al (1995) Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology 194:671–680PubMed Cognard C, Gobin YP, Pierot L et al (1995) Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology 194:671–680PubMed
37.
go back to reference Miyachi S, Izumi T, Matsubara N, Naito T, Haraguchi K, Wakabayashi T (2011) Mechanism of the formation of dural arteriovenous fistula: the role of the emissary vein. Interv Neuroradiol 17:195–202 Miyachi S, Izumi T, Matsubara N, Naito T, Haraguchi K, Wakabayashi T (2011) Mechanism of the formation of dural arteriovenous fistula: the role of the emissary vein. Interv Neuroradiol 17:195–202
38.
go back to reference Satomi J, Satoh K (2008) Epidemiology and etiology of dural arteriovenous fistula. Brain Nerve 60:883–886PubMed Satomi J, Satoh K (2008) Epidemiology and etiology of dural arteriovenous fistula. Brain Nerve 60:883–886PubMed
39.
go back to reference Cognard C, Casasco A, Toevi M, Houdart E, Chiras J, Merland JJ (1998) Dural arteriovenous fistulas as a cause of intracranial hypertension due to impairment of cranial venous outflow. J Neurol Neurosurg Psychiatry 65:308–316CrossRefPubMed Cognard C, Casasco A, Toevi M, Houdart E, Chiras J, Merland JJ (1998) Dural arteriovenous fistulas as a cause of intracranial hypertension due to impairment of cranial venous outflow. J Neurol Neurosurg Psychiatry 65:308–316CrossRefPubMed
Metadata
Title
Relationship between diabetes mellitus with dural arteriovenous fistula
Authors
Dong-Geun Lee
Lin Bo Zhao
Jae Ho Shim
Deok Hee Lee
Dae Chul Suh
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Neuroradiology / Issue 9/2013
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-013-1221-2

Other articles of this Issue 9/2013

Neuroradiology 9/2013 Go to the issue